210 related articles for article (PubMed ID: 29128645)
1. Kunitz-type protease inhibitor as a vaccine candidate against schistosomiasis mansoni.
Ranasinghe SL; Duke M; Harvie M; McManus DP
Int J Infect Dis; 2018 Jan; 66():26-32. PubMed ID: 29128645
[TBL] [Abstract][Full Text] [Related]
2.
Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
Front Immunol; 2018; 9():1762. PubMed ID: 30105029
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with enzymatically cleaved GPI-anchored proteins from Schistosoma mansoni induces protection against challenge infection.
Martins VP; Pinheiro CS; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Azevedo V; Castro-Borges W; Wilson RA; Oliveira SC
Clin Dev Immunol; 2012; 2012():962538. PubMed ID: 22927873
[TBL] [Abstract][Full Text] [Related]
4. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.
Cardoso FC; Macedo GC; Gava E; Kitten GT; Mati VL; de Melo AL; Caliari MV; Almeida GT; Venancio TM; Verjovski-Almeida S; Oliveira SC
PLoS Negl Trop Dis; 2008 Oct; 2(10):e308. PubMed ID: 18827884
[TBL] [Abstract][Full Text] [Related]
5. Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production.
Rezende CM; Silva MR; Santos IG; Silva GA; Gomes DA; Goes AM
Immunol Lett; 2011 Dec; 141(1):123-33. PubMed ID: 21945176
[TBL] [Abstract][Full Text] [Related]
6. Schistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection.
Farias LP; Cardoso FC; Miyasato PA; Montoya BO; Tararam CA; Roffato HK; Kawano T; Gazzinelli A; Correa-Oliveira R; Coulson PS; Wilson RA; Oliveira SC; Leite LC
PLoS Negl Trop Dis; 2010 Feb; 4(2):e597. PubMed ID: 20161725
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni.
Pearce EJ; Caspar P; Grzych JM; Lewis FA; Sher A
J Exp Med; 1991 Jan; 173(1):159-66. PubMed ID: 1824635
[TBL] [Abstract][Full Text] [Related]
8. Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection.
Martins VP; Morais SB; Pinheiro CS; Assis NR; Figueiredo BC; Ricci ND; Alves-Silva J; Caliari MV; Oliveira SC
PLoS Negl Trop Dis; 2014 Mar; 8(3):e2750. PubMed ID: 24651069
[TBL] [Abstract][Full Text] [Related]
9. Schistosome syntenin partially protects vaccinated mice against Schistosoma mansoni infection.
Figueiredo BC; Assis NR; Morais SB; Ricci ND; Pinheiro CS; Martins VP; Bicalho RM; Da'dara AA; Skelly PJ; Oliveira SC
PLoS Negl Trop Dis; 2014 Aug; 8(8):e3107. PubMed ID: 25144756
[TBL] [Abstract][Full Text] [Related]
10. Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone.
Fonseca CT; Pacífico LG; Barsante MM; Rassi T; Cassali GD; Oliveira SC
Microbes Infect; 2006 Aug; 8(9-10):2509-16. PubMed ID: 16914349
[TBL] [Abstract][Full Text] [Related]
11. Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine.
Pacífico LG; Fonseca CT; Chiari L; Oliveira SC
Immunobiology; 2006; 211(1-2):97-104. PubMed ID: 16446174
[TBL] [Abstract][Full Text] [Related]
12. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
[TBL] [Abstract][Full Text] [Related]
13. Peptides Derived of Kunitz-Type Serine Protease Inhibitor as Potential Vaccine Against Experimental Schistosomiasis.
Hernández-Goenaga J; López-Abán J; Protasio AV; Vicente Santiago B; Del Olmo E; Vanegas M; Fernández-Soto P; Patarroyo MA; Muro A
Front Immunol; 2019; 10():2498. PubMed ID: 31736947
[TBL] [Abstract][Full Text] [Related]
14. Schistosoma mansoni schistosomula tegument (Smteg) immunization in absence of adjuvant induce IL-10 production by CD4+ cells and failed to protect mice against challenge infection.
Araujo JM; de Melo TT; de Sena IC; Alves CC; Araujo N; Durães Fdo V; Oliveira SC; Fonseca CT
Acta Trop; 2012 Nov; 124(2):140-6. PubMed ID: 22842304
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of a novel Kunitz type protease inhibitor from the human blood fluke Schistosoma mansoni.
Ranasinghe SL; Fischer K; Gobert GN; McManus DP
Parasit Vectors; 2015 Aug; 8():408. PubMed ID: 26238343
[TBL] [Abstract][Full Text] [Related]
16. Innate immunogenicity and in vitro protective potential of Schistosoma mansoni lung schistosomula excretory--secretory candidate vaccine antigens.
El Ridi R; Tallima H; Mahana N; Dalton JP
Microbes Infect; 2010 Sep; 12(10):700-9. PubMed ID: 20452455
[TBL] [Abstract][Full Text] [Related]
17. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice.
Pinheiro CS; Ribeiro AP; Cardoso FC; Martins VP; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Loukas A; Oliveira SC
Parasite Immunol; 2014 Jul; 36(7):303-12. PubMed ID: 24749785
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.
Ricciardi A; Dalton JP; Ndao M
Vaccine; 2015 Jan; 33(2):346-53. PubMed ID: 25448114
[TBL] [Abstract][Full Text] [Related]
19. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni.
Hoffmann KF; James SL; Cheever AW; Wynn TA
J Immunol; 1999 Jul; 163(2):927-38. PubMed ID: 10395689
[TBL] [Abstract][Full Text] [Related]
20. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
El Ridi R; Tallima H
Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
